Stockscreener 앱 받기
0.80%
시간 외 거래:
전일 마감가:
$663.25
열려 있는:
$663.67
하루 거래량:
1.30M
Relative Volume:
1.54
시가총액:
$83.51B
수익:
$377.60B
순이익/손실:
$3.16B
주가수익비율:
26.66
EPS:
25.08
순현금흐름:
$5.67B
1주 성능:
-4.32%
1개월 성능:
-7.67%
6개월 성능:
+12.24%
1년 성능:
+22.11%
1일 변동 폭
$656.49
$671.40
1주일 범위
$648.60
$713.58
52주 변동 폭
$464.42
$737.89
맥케슨 Stock (MCK) Company Profile
명칭
Mckesson Corporation
전화
972-446-4800
주소
6555 STATE HIGHWAY 161, IRVING, TX
MCK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MCK
Mckesson Corporation
|
668.58 | 87.90B | 377.60B | 3.16B | 5.67B | 25.08 |
|
COR
Cencora Inc
|
285.13 | 55.00B | 316.65B | 1.90B | 1.14B | 9.72 |
|
CAH
Cardinal Health Inc
|
157.41 | 37.38B | 222.29B | 1.56B | 2.44B | 6.41 |
|
HSIC
Henry Schein Inc
|
65.94 | 8.04B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.71 | 654.07M | 2.22M | -5.63M | -1.68M | -0.24 |
맥케슨 Stock (MCK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-04 | 재개 | Mizuho | Neutral |
| 2024-11-07 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-09-24 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-09-05 | 재확인 | Leerink Partners | Outperform |
| 2024-08-08 | 재확인 | Mizuho | Neutral |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-12-14 | 개시 | Wells Fargo | Equal Weight |
| 2023-03-31 | 개시 | Citigroup | Buy |
| 2022-08-22 | 재개 | Morgan Stanley | Overweight |
| 2022-07-06 | 다운그레이드 | Argus | Buy → Hold |
| 2022-06-07 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2022-04-01 | 재개 | Credit Suisse | Outperform |
| 2022-02-04 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-01-07 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2021-11-02 | 재확인 | Barclays | Overweight |
| 2021-11-02 | 재확인 | BofA Securities | Buy |
| 2021-11-02 | 재확인 | Evercore ISI | Outperform |
| 2021-11-02 | 재확인 | Jefferies | Buy |
| 2021-03-30 | 업그레이드 | Argus | Hold → Buy |
| 2020-11-02 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2020-08-04 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2020-05-22 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2020-05-15 | 업그레이드 | UBS | Neutral → Buy |
| 2020-04-23 | 재개 | Credit Suisse | Neutral |
| 2020-03-18 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-03-13 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-02-07 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2020-01-10 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-12 | 개시 | Deutsche Bank | Hold |
| 2019-08-05 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2019-07-22 | 개시 | Guggenheim | Neutral |
| 2019-01-17 | 개시 | UBS | Neutral |
| 2018-10-26 | 재확인 | Barclays | Equal Weight |
| 2018-07-20 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2018-05-29 | 재확인 | Leerink Partners | Mkt Perform |
| 2018-03-08 | 개시 | Barclays | Equal Weight |
| 2018-02-27 | 재개 | BofA/Merrill | Buy |
| 2018-02-02 | 재확인 | Mizuho | Neutral |
| 2018-01-24 | 업그레이드 | Jefferies | Hold → Buy |
모두보기
맥케슨 주식(MCK)의 최신 뉴스
How McKesson’s (MCK) Earnings Beat, Dividend Hike, and Spin-Off Plans Have Changed Its Investment Story - simplywall.st
Published on: 2025-08-09 00:46:56 - Newser
Published on: 2025-08-08 22:45:07 - Newser
McKesson Climbs 0.80% Despite 99th-Ranked Trading Volume as Institutional Confidence and Dividend Hike Fuel Long-Term Optimism - AInvest
Pharmacy Profiles to provide credential verification services for McKesson's Health Mart pharmacies - Morningstar
Here's Why McKesson (MCK) is a Strong Value Stock - Yahoo Finance
Pharmaceutical Packaging Market Trends and Company Analysis - GlobeNewswire
Pharmaceutical Packaging Market Trends and Company Analysis Report 2025-2033 Featuring Amcor, 3M, Schott, WestRock, Berry Global, McKesson, AptarGroup, Klockner Pentaplast, CCL, FlexiTuff - Yahoo Finance
McKesson’s Strong Long-Term Growth Potential Justifies Buy Rating Despite Limited Immediate Upside - TipRanks
McKesson First Quarter 2026 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Candlestick signals on McKesson Corporation stock todayBreakout Watcher with Entry and Exit Alerts - Newser
Stock Analysis | McKesson OutlookTechnical Weakness and Mixed Analyst Signals - AInvest
McKesson’s Earnings Call Highlights Strong Growth and Strategic Moves - TipRanks
McKesson Corp. stock underperforms Thursday when compared to competitors - MSN
Relative Strength Alert For McKesson - Nasdaq
Deutsche Bank Adjusts Price Target on McKesson to $775 From $740, Maintains Buy Rating - MarketScreener
McKesson Corporation (NYSE:MCK) Q1 2026 Earnings Call Transcript - Insider Monkey
MCK Stock Down Despite Q1 Earnings Beat & Raised '26 EPS View - TradingView
McKesson Corp. Exceeds Expectations with Strong Q1 EarningsNews and Statistics - IndexBox
McKesson Increases Profit Forecast Due to Specialty Medicines DemandNews and Statistics - IndexBox
McKesson Achieves 23.4% Revenue Growth in Q2 CY2025News and Statistics - IndexBox
Earnings call transcript: McKesson’s Q1 2026 results exceed forecasts, stock dips - Investing.com Australia
McKesson Lifts Forecast As Specialty Medicine Demand Grows - Finimize
McKesson Corporation Reports Strong Q1 2026 Results - TipRanks
Decoding McKesson Corp (MCK): A Strategic SWOT Insight - GuruFocus
McKesson’s Strong Performance and Strategic Moves Earn a Buy Rating from Charles Rhyee - TipRanks
McKesson 0.81% Stock Slide Contrasts $97.8B Revenue Surge and Strategic Acquisitions as Trading Volume Ranks 105th - AInvest
McKesson reports Q1 adjusted EPS $8.26, consensus $8.15 - TipRanks
McKesson Well-Positioned to Benefit from GLP-1s and Increasing Presence in Specialty - Morningstar
Mckesson lifts annual profit forecast on robust demand for specialty drugs - MSN
McKesson: Fiscal Q1 Earnings Snapshot - Norwalk Hour
McKesson (MCK) Achieves Record Revenue, Raises Earnings Guidance - GuruFocus
McKesson's Q1 2026: Unraveling Contradictions on Rite Aid, Tariffs, and Market Dynamics - AInvest
McKesson's Strategic Transformation and Earnings Outperformance: A High-Conviction Buy for 2026 - AInvest
McKesson’s (NYSE:MCK) Q2 Sales Top Estimates - Yahoo Finance
Compared to Estimates, McKesson (MCK) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
MCKESSON CORP SEC 10-Q Report - TradingView
Mckesson Lifts Annual Profit Forecast on Robust Demand for Specialty Drugs - Money/ US News
McKesson falls 2.7% despite raising full-year outlook By Investing.com - Investing.com Australia
These 5 Dividend Growers Are Outperforming the Market in Total Return - Investing.com
McKesson Corp Reports Q1 Revenue of $97.8 Billion, Adjusted EPS of $8.26 Surpasses Estimates - GuruFocus
McKesson Q1 2026 slides: Revenue surges 23%, company raises full-year outlook - Investing.com India
McKesson Q1 2026 slides: Revenue surges 23%, company raises full-year outlook By Investing.com - Investing.com South Africa
McKesson earnings beat by $0.07, revenue topped estimates - Investing.com Canada
McKesson Fiscal Q1 Adjusted Earnings, Revenue Increase; Raises Fiscal 2026 Adjusted EPS Outlook - MarketScreener
McKesson Corporation Reports Fiscal 2026 First Quarter Results and Raises Full Year Adjusted EPS Guidance | MCK Stock News - GuruFocus
McKesson Corporation Reports Fiscal 2026 First Quarter Results and Raises Full Year Adjusted EPS Guidance - Business Wire
How To YieldBoost McKesson To 3.7% Using Options - Nasdaq
McKesson's (NYSE:MCK) Investors Will Be Pleased With Their Fantastic 384% Return Over the Last Five Years - 富途牛牛
McKesson Corporation (MCK): A Bull Case Theory - MSN
McKesson, Uber, Airbnb lead earnings reports Wednesday By Investing.com - Investing.com India
맥케슨 (MCK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.42%
1.72%
자본화:
|
볼륨(24시간):